Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Post by N00bInvesT0Ron Apr 15, 2019 2:12pm
165 Views
Post# 29629006

Aphria is a real diamond

Aphria is a real diamond
Aphria Net revenues  after excise taxes ( 73,582 M) : https://aphria.ca/wp-content/uploads/2019/04/aphria-Q3-2019-inerim-financial-statements.pdf

Weed Net revenues after excise taxes (83,048 M) :  https://www.canopygrowth.com/wp-content/uploads/2019/02/Canopy-Growth-Corporation_Q3_2019-Financial-Statements_FINAL.pdf

Aurora Net revenues after excise taxes (54,178 M) : https://aphria.ca/wp-content/uploads/2019/04/aphria-Q3-2019-inerim-financial-statements.pdf

Let me spare you the maths, Aphria has a market cap 4 times smaller than Aurora on top of having almost 5 times less outstanding shares (dilution horrible) yet they managed to outperform Aurora by 36%.

Aphria and Weed no dilution problems but Aphria almost 6.5 times small than Weed yet Weed only outperformed Aphria by 11%.

Doesn't take a genius to understand whats next for Aphria in terms of valuation if the market is willing to accept Weed and Aurora valuation after getting outshined by Aphria

(Yes I know its CC pharma and the Argentine company that generated the most, I can care less, at least Aphria acquisition brings value to shareholders unlike other Mj companies acquisitions)

Good luck
Bullboard Posts